This Viewpoint highlights the role of next-generation sequencing in the rapid emergence of new cancer therapies as well as the challenges of safely regulating these therapies without unnecessarily delaying their implementation.
No takes yet. Share an insight, caveat, or question.
Blumenthal et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: